Eventide Asset Management, Llc

13F Holdings History for Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)

Symbol: CLDX on Nasdaq
Investment type: Equity / Common Stock, par value $0.001
Latest Disclosed Ownership: 1.36M shares
Security Ownership: 2%

Shares, Excluding Options vs Price

Value, Excluding Options

Eventide Asset Management, LLC ownership in Celldex Therapeutics, Inc. Common Stock, par value $0.001 (CLDX)

2025-08-14 - Eventide Asset Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.36M shares of Celldex Therapeutics, Inc. Common Stock, par value $0.001 (CLDX). This represents 2% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Eventide Asset Management, LLC	2%		$30.6M	1.36M			$22.60	13G/A	6/30/2025	14 Aug 2025 14:59:36

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.48%	-0.86%	$27.6M	1.36M	-2,398,607	-63.9%	$20.35	Q2 2025
3/31/2025	1.36%	+0%	$68.2M	3.75M	+1,533		$18.16	Q1 2025
12/31/2024	1.73%	+0.19%	$94.8M	3.75M	+421,255	+12.6%	$25.27	Q4 2024
9/30/2024	1.95%	+0%	$113M	3.33M	+4,873	+0.15%	$33.99	Q3 2024
6/30/2024	2.11%	+0.12%	$123M	3.33M	+208,045	+6.67%	$37.01	Q2 2024
3/31/2024	2.05%	-0.35%	$131M	3.12M	-510,926	-14.1%	$41.97	Q1 2024
12/31/2023	2.35%	+1.45%	$144M	3.63M	+2,030,013	+127%	$39.66	Q4 2023
9/30/2023	0.79%	+0.11%	$44M	1.6M	+222,260	+16.1%	$27.52	Q3 2023
6/30/2023	0.79%		$46.7M	1.38M			$33.93	Q2 2023
3/31/2023	0.91%	-0.06%	$49.6M	1.38M	-85,310	-5.83%	$35.98	Q1 2023
12/31/2022	1.29%	-0.29%	$65.2M	1.46M	-328,750	-18.3%	$44.57	Q4 2022
9/30/2022	0.99%	+0.19%	$50.4M	1.79M	+346,100	+23.9%	$28.11	Q3 2022
6/30/2022	0.83%		$39M	1.45M			$26.96	Q2 2022
3/31/2022	0.77%	+0.11%	$49.2M	1.45M	+206,800	+16.7%	$34.06	Q1 2022
12/31/2021	0.61%	+0.05%	$47.9M	1.24M	+110,900	+9.83%	$38.64	Q4 2021
9/30/2021	0.81%	-0.71%	$60.9M	1.13M	-980,908	-46.5%	$53.99	Q3 2021
6/30/2021	0.95%	+0.02%	$70.5M	2.11M	+46,475	+2.25%	$33.44	Q2 2021
3/31/2021	0.63%	+0.07%	$42.5M	2.06M	+225,325	+12.3%	$20.60	Q1 2021
12/31/2020	0.49%	+0.36%	$32.2M	1.84M	+1,330,929	+263%	$17.52	Q4 2020
9/30/2020	0.15%	+0.01%	$7.51M	506K	+42,844	+9.25%	$14.83	Q3 2020
6/30/2020	0.13%	+0.13%	$6.02M	463K	+463,335	NEW	$13.00	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.